S 526 New Jersey Senate · 2020-2021 Regular Session

Provides that purchase of insulin is not subject to deductible and requires health insurers to limit copayments and coinsurance for insulin.**

Bill status passed 3 of 5 stages cleared
Introduction
Jan 2020
Committee Review
Mar 2021
Senate Passage
Nov 2020
General Assembly Passage
Governor
Introduced Jan 14, 2020 Last action Mar 17, 2021
Floor votes · Senate Nov 16, 2020

How they voted

380
Passed · 1 other
Total votes 39
Nov 16, 2020
D Democratic26
25 Yea 1
96% Yea
R Republican13
13 Yea
100% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
8
Key actions
4
Committee
6
Mar 17, 2021
Committee
Recommitted to Assembly Appropriations Committee
lower
Feb 24, 2021
Lower · Passed
Reported out of Assembly Committee with Amendments, 2nd Reading
lower
Nov 16, 2020
Committee
Received in the Assembly, Referred to Assembly Appropriations Committee
lower
Nov 16, 2020
Upper · Passed
Passed Senate (39-0)
upper
Nov 9, 2020
Upper · Passed
Reported out of Senate Committee with Amendments, 2nd Reading
upper
Jan 27, 2020
Committee
Referred to Senate Budget and Appropriations Committee
upper
Jan 27, 2020
Upper · Passed
Reported out of Senate Committee with Amendments, 2nd Reading
upper
Jan 14, 2020
Introduced
Introduced in the Senate, Referred to Senate Commerce Committee
upper
3 primary · 5 co-sponsors

Sponsors